<DOC>
	<DOCNO>NCT02492594</DOCNO>
	<brief_summary>Invasive fungal infection ( IFI ) immunocompromised patient pose major challenge diagnostics design permit timely onset appropriate treatment . The aim current clinical-diagnostic study , one pediatric one adult patient high risk IFI , test newly develop diagnostic approach invasive fungal infection relation establish procedure . The study perform prospective , blinded fashion , represent work package within FUNGITECT grant support European Commission . The study focus analysis blood-samples patient febrile neutropenia treatment acute leukemia hematopoietic stem cell transplantation .</brief_summary>
	<brief_title>Optimized Diagnostics Improved Therapy Stratification Invasive Fungal Infections</brief_title>
	<detailed_description>Samples immunosuppressed patient febrile neutropenia take : - start neutropenic fever - 24 hour - 48 hour - start antimycotic therapy , pertinent - end antimycotic therapy , pertinent The result ot analyse panfungal PCR screen assay develop institution ( European patent No 1960536 ) method newly develop FUNGITECT project compare conventional method fungal diagnostics HR ( High Resolution ) -CT , serological testing , histology fungal culture . Additionally , genomic approach employ investigate host- pathogen-related factor susceptibility , pathogenicity antimycotic resistance .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<criteria>Adult study : Patients 1890 year age high risk invasive fungal infection ( individual acute leukemia chemotherapy/allogeneic stem cell transplant recipient ) , sign informed consent Pediatric study : patient 018 year age high risk invasive fungal infection ( individual acute leukemia chemotherapy/allogeneic stem cell transplant recipient ) , sign informed consent Exclusion criterion : Adult study : pregnancy , sign informed consent Pediatric study sign informed consent</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>